William Aird: Developing Patient-Facing Educational Material for The Blood Project
William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
“We have been developing patient-facing educational material for The Blood Project, and one recurring theme is that common hematologic findings are often not dangerous, but they are often poorly explained.
Thalassemia trait is a good example.
Many patients are told they ‘have thalassemia’ without a clear explanation of what that means.
They may worry that they have a serious blood disease, that they will become ill, or that they need treatment.
It is common.
It is usually benign.
And it is often poorly explained.
Thalassemia trait is not a disease in the usual sense.
It is a common inherited hemoglobin variant, found at high frequency in parts of the world where malaria has exerted powerful evolutionary pressure.
For the individual carrier, it may cause small red blood cells and sometimes mild anemia, but it usually does not cause symptoms or require treatment.
What it does require is explanation.
Patients need to know:
- this is inherited, not acquired
- it is not iron deficiency
- iron should not be given unless iron deficiency is actually present
- family planning may matter if a partner also carries a hemoglobin variant
- the CBC may look ‘abnormal’ even when the patient is well
In other words, the problem is often not the trait.
The problem is the explanation.
We created this short patient-facing guide for The Blood Project to help clinicians and patients have a clearer conversation.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026